Natco Pharma Receives Warning Letter From US Health Regulator
2 weeks ago•Bloomberg Quint
U.S. FDA issues warning letter to Natco over facility near Hyderabad
2 weeks ago•The Hindu
Natco Pharma Trades Close To Its 52-Week High; Nuvama Expects India Biz To Pick Up In FY25
2 months ago•CNBC-TV18
Natco Pharma Q3 net surges to ₹213 cr. on higher revenue
2 months ago•The Hindu
Natco Pharma Q3 net profit rises over 3-fold to Rs 212.7 crore
2 months ago•Moneycontrol
Natco Pharma Q2 Results Review - Strong Growth On Low Base; Weak Q3 Expected: Nirmal Bang
5 months ago•Bloomberg Quint
Natco Pharma Q2 Results Review - Miss On Earnings: Dolat Capital
5 months ago•Bloomberg Quint